Russian Clinical Trials Weather The COVID-19 Storm
66 Coronavirus Studies OKd in 2020
While the total number of clinical trials given the go-ahead in Russia saw only a very small decline last year, average timelines for study approvals increased significantly because of factors linked to COVID-19.
You may also be interested in...
The EU vaunts its vaccine donations and starts building resilience against future health threats, and the UK MHRA says Moderna can be used as a booster dose. Aviptadil has received scientific advice from the MHRA for its potential use as a treatment for COVID-19 patients.
While the UK and other countries are implementing or considering additional vaccination campaigns, questions have been raised about the impact on lower-income countries, and COVAX has called on donors and manufactures to honor their vaccine supply commitments.
Having decided to suspend 12 million doses of Sinovac’s coronavirus vaccine, Brazil’s regulatory agency says it will need to make its own on-site assessment of conditions at the Chinese facility that makes the product.